HDAC6 and systemic lupus erythematosus: ACY-738 treatment of mice increased a total of 5 canonical pathways, and none were significantly decreased in human SLE although glutathione mediated detoxification (Z = 3.5 in HDAC6 inhibitor treated mice) had negative Z scores for human lupus skin (−1.8) and lupus nephritis (−1.6).